Idarubicin: all 110 studies that test it
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous LeukemiaWithdrawnNCT00003405Phase 2
- Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00003268Phase 1
- Chemotherapy in Treating Children With Recurrent Acute Myeloid LeukemiaCompletedNCT00003178Phase 2
- Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeStatus unknownNCT00002989Phase 3
- High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00002945Phase 3
- Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
- Combination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaCompletedNCT00002812Phase 3
- Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002800Phase 2
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic LeukemiaStatus unknownNCT00002701Phase 3
- Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3